Line 1: |
Line 1: |
− | ==Myeloproliferative Neoplasms (MPN) ([[Myeloproliferative Neoplasms (MPN)|Overview Page Link]])== | + | ==Myeloproliferative Neoplasms (MPN) ([[HAEM4:Myeloproliferative Neoplasms (MPN)|Overview Page Link]])== |
| | | |
− | *[[Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive]] | + | *[[HAEM5:Chronic myeloid leukaemia]] |
− | *[[Chronic Neutrophilic Leukemia (CNL)]] | + | *[[HAEM5:Chronic neutrophilic leukaemia]] |
− | *[[Polycythemia Vera (PV)]] | + | *[[HAEM5:Polycythaemia vera]] |
− | *[[Primary Myelofibrosis (PMF)]] | + | *[[HAEM5:Primary myelofibrosis]] |
− | *[[Essential Thrombocythemia (ET)]] | + | *[[HAEM5:Essential thrombocythaemia]] |
− | *[[Chronic Eosinophilic Leukemia, Not Otherwise Specified]] | + | *[[HAEM5:Chronic eosinophilic leukaemia]] |
− | *[[Myeloproliferative Neoplasm (MPN), Unclassifiable]] | + | *[[HAEM5:Myeloproliferative neoplasm, NOS]] |
| | | |
− | ==Mastocytosis ([[Mastocytosis|Overview Page Link]])== | + | ==Mastocytosis ([[HAEM4:Mastocytosis|Overview Page Link]])== |
| | | |
− | *[[Cutaneous Mastocytosis]] | + | *[[HAEM5:Cutaneous mastocytosis]] |
− | *[[Systemic Mastocytosis]] | + | *[[HAEM5:Systemic mastocytosis]] |
− | *[[Mast Cell Sarcoma]] | + | *[[HAEM5:Mast cell sarcoma]] |
| | | |
− | ==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 ([[Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2|Overview Page Link]])== | + | ==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 ([[HAEM4:Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2|Overview Page Link]])== |
| | | |
− | *[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]] | + | *[[HAEM5:Myeloid/lymphoid neoplasm with PDGFRA rearrangement]] |
− | *[[Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement]] | + | *[[HAEM5:Myeloid/lymphoid neoplasm with PDGFRB rearrangement]] |
− | *[[Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement]] | + | *[[HAEM5:Myeloid/lymphoid neoplasm with FGFR1 rearrangement]] |
− | *[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]] | + | *[[HAEM5:Myeloid/lymphoid neoplasm with JAK2 rearrangement]] |
| | | |
− | ==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) ([[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Overview Page Link]])== | + | ==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) ([[HAEM4:Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Overview Page Link]])== |
| | | |
− | *[[Chronic Myelomonocytic Leukemia (CMML)]] | + | *[[HAEM5:Chronic myelomonocytic leukaemia]] |
− | *[[Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative]] | + | *[[HAEM5:Myelodysplastic/myeloproliferative neoplasm with neutrophilia]] |
− | *[[Juvenile Myelomonocytic Leukemia (JMML)]] | + | *[[HAEM5:Juvenile myelomonocytic leukaemia]] |
− | *[[Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)|MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]] | + | *[[HAEM5:Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis|MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]] |
− | *[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]] | + | *[[HAEM4:Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]] |
| | | |
− | ==Myelodysplastic Syndromes (MDS) ([[Myelodysplastic Syndromes (MDS)|Overview Page Link]])== | + | ==Myelodysplastic Syndromes (MDS) ([[HAEM4:Myelodysplastic Syndromes (MDS)|Overview Page Link]])== |
| | | |
− | *[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]] | + | *[[HAEM4:Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]] |
− | *[[Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)|MDS with Ring Sideroblasts (MDS-RS)]] | + | *[[HAEM4:Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)|MDS with Ring Sideroblasts (MDS-RS)]] |
− | *[[Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia|MDS with Ring Sideroblasts and Multilineage Dysplasia]] | + | *[[HAEM4:Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia|MDS with Ring Sideroblasts and Multilineage Dysplasia]] |
− | *[[Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia|MDS with Multilineage Dysplasia]] | + | *[[HAEM4:Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia|MDS with Multilineage Dysplasia]] |
− | *[[Myelodysplastic Syndrome (MDS) with Excess Blasts|MDS with Excess Blasts]] | + | *[[HAEM5:Myelodysplastic neoplasm with increased blasts|MDS with Excess Blasts]] |
− | *[[Myelodysplastic Syndrome (MDS) with Isolated del(5q)|MDS with Isolated del(5q)]] | + | *[[HAEM5:Myelodysplastic neoplasm with low blasts and 5q deletion|MDS with Isolated del(5q)]] |
− | *[[Myelodysplastic Syndrome (MDS), Unclassifiable|MDS, Unclassifiable]] | + | *[[HAEM4:Myelodysplastic Syndrome (MDS), Unclassifiable|MDS, Unclassifiable]] |
− | *[[Refractory Cytopenia of Childhood]] | + | *[[HAEM4:Refractory Cytopenia of Childhood]] |
| | | |
− | ==Myeloid Neoplasms with Germline Predisposition ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== | + | ==Myeloid Neoplasms with Germline Predisposition ([[HAEM4:Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== |
| | | |
− | *[[Acute Myeloid Leukaemia with Germline CEBPA Mutation]] | + | *[[HAEM4:Acute Myeloid Leukaemia with Germline CEBPA Mutation]] |
− | *[[Myeloid Neoplasms with Germline DDX41 Mutation]] | + | *[[HAEM4:Myeloid Neoplasms with Germline DDX41 Mutation]] |
− | *[[Myeloid Neoplasms with Germline RUNX1 Mutation]] | + | *[[HAEM4:Myeloid Neoplasms with Germline RUNX1 Mutation]] |
− | *[[Myeloid Neoplasms with Germline ANKRD26 Mutation]] | + | *[[HAEM4:Myeloid Neoplasms with Germline ANKRD26 Mutation]] |
− | *[[Myeloid Neoplasms with Germline ETV6 Mutation]] | + | *[[HAEM4:Myeloid Neoplasms with Germline ETV6 Mutation]] |
− | *[[Myeloid Neoplasms with Germline GATA2 Mutation]] | + | *[[HAEM4:Myeloid Neoplasms with Germline GATA2 Mutation]] |
| | | |
− | ==Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== | + | ==Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms ([[HAEM4:Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== |
| | | |
− | *[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]] | + | *[[HAEM4:Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]] |
| | | |
− | - [[Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1|AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]] | + | - [[HAEM5:Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion|AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]] |
− | - [[Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11|AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] | + | - [[HAEM5:Acute myeloid leukaemia with CBFB::MYH11 fusion|AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] |
− | - [[Acute Promyelocytic Leukemia (APL) with PML-RARA]] | + | - [[HAEM5:Acute promyelocytic leukaemia with PML::RARA fusion]] |
− | - [[Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3|AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]] | + | - [[HAEM5:Acute myeloid leukaemia with KMT2A rearrangement|AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]] |
− | - [[Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214|AML with t(6;9)(p23;q34.1); DEK-NUP214]] | + | - [[HAEM5:Acute myeloid leukaemia with DEK::NUP214 fusion|AML with t(6;9)(p23;q34.1); DEK-NUP214]] |
− | - [[Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM|AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]] | + | - [[HAEM5:Acute myeloid leukaemia with MECOM rearrangement|AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]] |
− | - [[Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1|AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]] | + | - [[HAEM5:Acute myeloid leukaemia with RBM15::MRTFA fusion|AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]] |
− | - [[Acute Myeloid Leukemia (AML) with BCR-ABL1|AML with BCR-ABL1]] | + | - [[HAEM5:Acute myeloid leukaemia with BCR::ABL1 fusion|AML with BCR-ABL1]] |
− | - [[Acute Myeloid Leukemia (AML) with Mutated NPM1|AML with Mutated NPM1]] | + | - [[HAEM5:Acute myeloid leukaemia with NPM1 mutation|AML with Mutated NPM1]] |
− | - [[Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA|AML with Biallelic Mutations of CEBPA]] | + | - [[HAEM5:Acute myeloid leukaemia with CEBPA mutation|AML with Biallelic Mutations of CEBPA]] |
− | - [[Acute Myeloid Leukemia (AML) with Mutated RUNX1|AML with Mutated RUNX1]] | + | - [[HAEM4:Acute Myeloid Leukemia (AML) with Mutated RUNX1|AML with Mutated RUNX1]] |
| | | |
− | *[[Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes|AML with Myelodysplasia-Related Changes]] | + | *[[HAEM5:Acute myeloid leukaemia, myelodysplasia-related|AML with Myelodysplasia-Related Changes]] |
| | | |
− | *[[Therapy-Related Myeloid Neoplasms]] | + | *[[HAEM5:Myeloid neoplasm post cytotoxic therapy]] |
| | | |
− | *[[Acute Myeloid Leukemia (AML), Not Otherwise Specified|AML, Not Otherwise Specified]] | + | *[[HAEM4:Acute Myeloid Leukemia (AML), Not Otherwise Specified|AML, Not Otherwise Specified]] |
| | | |
− | - [[Acute Myeloid Leukemia (AML) with Minimal Differentiation|AML with Minimal Differentiation]] | + | - [[HAEM5:Acute myeloid leukaemia with minimal differentiation|AML with Minimal Differentiation]] |
− | - [[Acute Myeloid Leukemia (AML) without Maturation|AML without Maturation]] | + | - [[HAEM5:Acute myeloid leukaemia without maturation|AML without Maturation]] |
− | - [[Acute Myeloid Leukemia (AML) with Maturation|AML with Maturation]] | + | - [[HAEM5:Acute myeloid leukaemia with maturation|AML with Maturation]] |
− | - [[Acute Myelomonocytic Leukemia]] | + | - [[HAEM5:Acute myelomonocytic leukaemia]] |
− | - [[Acute Monoblastic and Monocytic Leukemia]] | + | - [[HAEM5:Acute monocytic leukaemia]] |
− | - [[Pure Erythroid Leukemia]] | + | - [[HAEM5:Acute erythroid leukaemia]] |
− | - [[Acute Megakaryoblastic Leukemia (AMKL)]] | + | - [[HAEM5:Acute megakaryoblastic leukaemia]] |
− | - [[Acute Basophilic Leukemia]] | + | - [[HAEM5:Acute basophilic leukaemia]] |
− | - [[Acute Panmyelosis with Myelofibrosis]] | + | - [[HAEM4:Acute Panmyelosis with Myelofibrosis]] |
| | | |
− | *[[Myeloid Sarcoma]] | + | *[[HAEM5:Myeloid sarcoma]] |
| | | |
− | *[[Myeloid Proliferations Associated with Down Syndrome]] | + | *[[HAEM4:Myeloid Proliferations Associated with Down Syndrome]] |
| | | |
− | - [[Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome]] | + | - [[HAEM5:Myeloid proliferations associated with Down syndrome]] |
− | - [[Myeloid Leukemia Associated with Down Syndrome]] | + | - [[HAEM5:Myeloid proliferations associated with Down syndrome]] |
| | | |
− | ==Blastic Plasmacytoid Dendritic Cell Neoplasm ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== | + | ==Blastic Plasmacytoid Dendritic Cell Neoplasm ([[HAEM4:Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== |
| | | |
− | *[[Blastic Plasmacytoid Dendritic Cell Neoplasm]] | + | *[[HAEM5:Blastic plasmacytoid dendritic cell neoplasm]] |
| | | |
− | ==Acute Leukemias of Ambiguous Lineage (MPAL) ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== | + | ==Acute Leukemias of Ambiguous Lineage (MPAL) ([[HAEM4:Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== |
| | | |
− | *[[Acute Leukemias of Ambiguous Lineage]] | + | *[[HAEM4:Acute Leukemias of Ambiguous Lineage]] |
| | | |
− | - [[Acute Undifferentiated Leukemia]] | + | - [[HAEM5:Acute undifferentiated leukaemia]] |
− | - [[Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1]] | + | - [[HAEM5:Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]] |
− | - [[Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged]] | + | - [[HAEM5:Mixed-phenotype acute leukaemia with KMT2A rearrangement]] |
− | - [[Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified]] | + | - [[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid]] |
− | - [[Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified]] | + | - [[HAEM5:Mixed-phenotype acute leukaemia, T/myeloid]] |
− | - [[Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types]] | + | - [[HAEM5:Mixed-phenotype acute leukaemia, rare types]] |
− | - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] | + | - [[HAEM4:Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] |
| | | |
− | ==Precursor Lymphoid Neoplasms (B-ALL, T-ALL) ([[Precursor Lymphoid Neoplasms|Overview Page Link]])== | + | ==Precursor Lymphoid Neoplasms (B-ALL, T-ALL) ([[HAEM4:Precursor Lymphoid Neoplasms|Overview Page Link]])== |
| | | |
− | *[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]] | + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]] |
| | | |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1|B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1]] | + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion|B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged|B-ALL with t(v;11q23.3); KMT2A-Rearranged]] | + | - [[HAEM5:B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement|B-ALL with t(v;11q23.3); KMT2A-Rearranged]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1|B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1]] | + | - [[HAEM5:B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion|B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy|B-ALL with Hyperdiploidy]] | + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy|B-ALL with Hyperdiploidy]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy|B-ALL with Hypodiploidy]] | + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy|B-ALL with Hypodiploidy]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3|B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3]] | + | - [[HAEM5:B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion|B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1|B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1]] | + | - [[HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion|B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like|B-ALL, BCR-ABL1-Like]] | + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features|B-ALL, BCR-ABL1-Like]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma with iAMP21|B-ALL with iAMP21]] | + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21|B-ALL with iAMP21]] |
− | - [[B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified|B-ALL, Not Otherwise Specified]] | + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma|B-ALL, Not Otherwise Specified]] |
| | | |
− | *[[T-Lymphoblastic Leukemia/Lymphoma|T-Lymphoblastic Leukemia/Lymphoma (T-ALL)]] | + | *[[HAEM4:T-Lymphoblastic Leukemia/Lymphoma|T-Lymphoblastic Leukemia/Lymphoma (T-ALL)]] |
| | | |
− | - [[Early T-Cell Precursor Lymphoblastic Leukemia]] | + | - [[HAEM5:Early T-precursor lymphoblastic leukaemia / lymphoma]] |
− | - [[NK-Lymphoblastic Leukemia/Lymphoma]] | + | - [[HAEM4:NK-Lymphoblastic Leukemia/Lymphoma]] |
| | | |
− | ==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas) ([[Mature B-Cell Neoplasms|Overview Page Link]])== | + | ==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas) ([[HAEM4:Mature B-Cell Neoplasms|Overview Page Link]])== |
| | | |
− | *[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]] | + | *[[HAEM5:Chronic lymphocytic leukaemia/small lymphocytic lymphoma]] |
| | | |
− | - [[Monoclonal B-cell Lymphocytosis]] | + | - [[HAEM5:Monoclonal B-cell lymphocytosis]] |
| | | |
− | *[[B-cell Prolymphocytic Leukemia]] | + | *[[HAEM4:B-cell Prolymphocytic Leukemia]] |
| | | |
− | *[[Splenic Marginal Zone Lymphoma]] | + | *[[HAEM5:Splenic marginal zone lymphoma]] |
| | | |
− | *[[Hairy Cell Leukemia]] | + | *[[HAEM5:Hairy cell leukaemia]] |
| | | |
− | *[[Splenic B-cell Lymphoma/Leukemia, Unclassifiable]] | + | *[[HAEM4:Splenic B-cell Lymphoma/Leukemia, Unclassifiable]] |
| | | |
− | - [[Splenic Diffuse Red Pulp Small B-cell Lymphoma]] | + | - [[HAEM5:Splenic diffuse red pulp small B-cell lymphoma]] |
− | - [[Hairy Cell Leukemia Variant]] | + | - [[HAEM5:Hairy cell leukaemia Variant]] |
| | | |
− | *[[Lymphoplasmacytic Lymphoma]] | + | *[[HAEM5:Lymphoplasmacytic lymphoma]] |
| | | |
− | - [[Waldenstrom Macroglobulinemia]] | + | - [[HAEM5:Lymphoplasmacytic lymphoma]] |
| | | |
− | *[[IgM Monoclonal Gammopathy of Undetermined Significance]] | + | *[[HAEM5:IgM monoclonal gammopathy of undetermined significance]] |
| | | |
− | *[[Heavy Chain Diseases]] | + | *[[HAEM4:Heavy Chain Diseases]] |
| | | |
− | - [[Mu Heavy Chain Disease]] | + | - [[HAEM5:Mu heavy chain disease]] |
− | - [[Gamma Heavy Chain Disease]] | + | - [[HAEM5:Gamma heavy chain disease]] |
− | - [[Alpha Heavy Chain Disease]] | + | - [[HAEM5:Alpha heavy chain disease]] |
| | | |
− | *[[Plasma Cell Neoplasms]] | + | *[[HAEM4:Plasma Cell Neoplasms]] |
| | | |
− | - [[Non-IgM Monoclonal Gammopathy of Undetermined Significance]] | + | - [[HAEM5:Non-IgM monoclonal gammopathy of undetermined significance]] |
− | - [[Plasma Cell Myeloma]] | + | - [[HAEM5:Plasma cell myeloma / multiple myeloma]] |
− | - [[Plasma Cell Myeloma Variants]] | + | - [[HAEM5:Plasma cell myeloma / multiple myeloma Variants]] |
− | - [[Plasmacytoma]] | + | - [[HAEM5:Plasmacytoma]] |
− | - [[Monoclonal Immunoglobulin Deposition Diseases]] | + | - [[HAEM4:Monoclonal Immunoglobulin Deposition Diseases]] |
− | - [[Primary Amyloidosis]] | + | - [[HAEM5:Immunoglobulin-related (AL) amyloidosis]] |
− | - [[Light Chain and Heavy Chain Deposition Disease]] | + | - [[HAEM5:Monoclonal immunoglobulin deposition disease]] |
− | - [[Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome]] | + | - [[HAEM4:Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome]] |
− | - [[POEMS Syndrome]] | + | - [[HAEM5:Plasma cell neoplasms with associated paraneoplastic syndrome]] |
− | - [[TEMPI Syndrome]] | + | - [[HAEM5:Plasma cell neoplasms with associated paraneoplastic syndrome]] |
| | | |
− | *[[Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)]] | + | *[[HAEM5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue]] |
| | | |
− | *[[Nodal Marginal Zone Lymphoma]] | + | *[[HAEM5:Nodal marginal zone lymphoma]] |
| | | |
− | - [[Paediatric Nodal Marginal Zone Lymphoma]] | + | - [[HAEM5:Paediatric nodal marginal zone lymphoma]] |
| | | |
− | *[[Follicular Lymphoma]] | + | *[[HAEM5:Follicular lymphoma]] |
| | | |
− | - [[Testicular Follicular Lymphoma]] | + | - [[HAEM5:Follicular lymphoma]] |
− | - [[In Situ Follicular Neoplasia]] | + | - [[HAEM5:In situ follicular B-cell neoplasm]] |
− | - [[Duodenal-Type Follicular Lymphoma]] | + | - [[HAEM5:Duodenal-type follicular lymphoma]] |
| | | |
− | *[[Paediatric-Type Follicular Lymphoma]] | + | *[[HAEM5:Paediatric-type follicular lymphoma]] |
| | | |
− | *[[Large B-cell Lymphoma with IRF4 Rearrangement]] | + | *[[HAEM5:Large B-cell lymphoma with IRF4 rearrangement]] |
| | | |
− | *[[Primary Cutaneous Follicle Centre Lymphoma]] | + | *[[HAEM5:Primary cutaneous follicle centre lymphoma]] |
| | | |
− | *[[Mantle Cell Lymphoma]] | + | *[[HAEM5:Mantle cell lymphoma]] |
| | | |
− | - [[Leukemic Non-Nodal Mantle Cell Lymphoma]] | + | - [[HAEM5:Leukaemic non-nodal mantle cell lymphoma]] |
− | - [[In Situ Mantle Cell Neoplasia]] | + | - [[HAEM5:In situ mantle cell neoplasm]] |
| | | |
− | *[[Diffuse Large B-cell Lymphoma, Not Otherwise Specified]] | + | *[[HAEM4:Diffuse Large B-cell Lymphoma, Not Otherwise Specified]] |
| | | |
− | *[[T-cell/Histiocyte-Rich Large B-cell Lymphoma]] | + | *[[HAEM5:T-cell/histiocyte-rich large B-cell lymphoma]] |
| | | |
− | *[[Primary Diffuse Large B-cell Lymphoma of the CNS]] | + | *[[HAEM5:Primary large B-cell lymphoma of immune-privileged sites]] |
| | | |
− | *[[Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type]] | + | *[[HAEM5:Primary cutaneous diffuse large B-cell lymphoma, leg type]] |
| | | |
− | *[[EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)]] | + | *[[HAEM5:EBV-positive diffuse large B-cell lymphoma]] |
| | | |
− | *[[EBV-Positive Mucocutaneous Ulcer]] | + | *[[HAEM5:EBV-positive mucocutaneous ulcer]] |
| | | |
− | *[[Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation]] | + | *[[HAEM5:Diffuse large B-cell lymphoma associated with chronic inflammation]] |
| | | |
− | - [[Fibrin-Associated Diffuse Large B-cell Lymphoma]] | + | - [[HAEM5:Fibrin-associated large B-cell lymphoma]] |
| | | |
− | *[[Lymphomatoid Granulomatosis]] | + | *[[HAEM5:Lymphomatoid granulomatosis]] |
| | | |
− | *[[Primary Mediastinal (Thymic) Large B-cell Lymphoma]] | + | *[[HAEM5:Primary mediastinal large B-cell lymphoma]] |
| | | |
− | *[[Intravascular Large B-cell Lymphoma]] | + | *[[HAEM5:Intravascular large B-cell lymphoma]] |
| | | |
− | *[[ALK-Positive Large B-cell Lymphoma]] | + | *[[HAEM5:ALK-positive large B-cell lymphoma]] |
| | | |
− | *[[Plasmablastic Lymphoma]] | + | *[[HAEM5:Plasmablastic lymphoma]] |
| | | |
− | *[[Primary Effusion Lymphoma]] | + | *[[HAEM5:Primary effusion lymphoma]] |
| | | |
− | *[[HHV8-Associated Lymphoproliferative Disorders]] | + | *[[HAEM4:HHV8-Associated Lymphoproliferative Disorders]] |
| | | |
− | - [[Multicentric Castleman Disease]] | + | - [[HAEM5:KSHV/HHV8-associated multicentric Castleman disease]] |
− | - [[HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)]] | + | - [[HAEM5:KSHV/HHV8-positive diffuse large B-cell lymphoma]] |
− | - [[HHV8-Positive Germinotropic Lymphoproliferative Disorder]] | + | - [[HAEM5:KSHV/HHV8-positive germinotropic lymphoproliferative disorder]] |
| | | |
− | *[[Burkitt Lymphoma]] | + | *[[HAEM5:Burkitt lymphoma]] |
| | | |
− | *[[Burkitt-Like Lymphoma with 11q Aberration]] | + | *[[HAEM5:High grade B-cell lymphoma with 11q aberrations]] |
| | | |
− | *[[High-Grade B-cell Lymphoma]] | + | *[[HAEM4:High-Grade B-cell Lymphoma]] |
| | | |
− | - [[High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements]] | + | - [[HAEM4:High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements]] |
− | - [[High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)]] | + | - [[HAEM4:High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)]] |
| | | |
− | *[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]] | + | *[[HAEM5:Mediastinal grey zone lymphoma]] |
| | | |
− | ==Mature T- and NK-cell Neoplasms ([[Mature T- and NK-cell Neoplasms|Overview Page Link]])== | + | ==Mature T- and NK-cell Neoplasms ([[HAEM4:Mature T- and NK-cell Neoplasms|Overview Page Link]])== |
| | | |
− | *[[T-cell Prolymphocytic Leukemia]] | + | *[[HAEM5:T-prolymphocytic leukaemia]] |
| | | |
− | *[[T-cell Large Granular Lymphocytic Leukemia]] | + | *[[HAEM5:T-large granular lymphocytic leukaemia]] |
| | | |
− | *[[Chronic Lymphoproliferative Disorder of NK Cells]] | + | *[[HAEM5:NK-large granular lymphocytic leukaemia]] |
| | | |
− | *[[Aggressive NK-cell Leukemia]] | + | *[[HAEM5:Aggressive NK-cell leukaemia]] |
| | | |
− | *[[EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood]] | + | *[[HAEM4:EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood]] |
| | | |
− | - [[Systemic EBV-Positive T-cell Lymphoma of Childhood]] | + | - [[HAEM5:Systemic EBV-positive T-cell lymphoma of childhood]] |
− | - [[Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form]] | + | - [[HAEM5:Systemic chronic active EBV disease]] |
− | - [[Hydroa Vacciniforme-Like Lymphoproliferative Disorder]] | + | - [[HAEM5:Hydroa vacciniforme lymphoproliferative disorder]] |
− | - [[Severe Mosquito Bite Allergy]] | + | - [[HAEM5:Severe mosquito bite allergy]] |
| | | |
− | *[[Adult T-cell Leukemia/Lymphoma]] | + | *[[HAEM5:Adult T-cell leukaemia/lymphoma]] |
| | | |
− | *[[Extranodal NK/T-cell Lymphoma, Nasal Type]] | + | *[[HAEM5:Extranodal NK/T-cell lymphoma]] |
| | | |
− | *[[Intestinal T-cell Lymphoma]] | + | *[[HAEM4:Intestinal T-cell Lymphoma]] |
| | | |
− | - [[Enteropathy-Associated T-cell Lymphoma]] | + | - [[HAEM5:Enteropathy-associated T-cell lymphoma]] |
− | - [[Monomorphic Epitheliotropic Intestinal T-cell Lymphoma]] | + | - [[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma]] |
− | - [[Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)]] | + | - [[HAEM4:Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)]] |
− | - [[Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract]] | + | - [[HAEM5:Indolent T-cell lymphoma of the gastrointestinal tract]] |
| | | |
− | *[[Hepatosplenic T-cell Lymphoma]] | + | *[[HAEM5:Hepatosplenic T-cell lymphoma]] |
| | | |
− | *[[Subcutaneous Panniculitis-Like T-cell Lymphoma]] | + | *[[HAEM5:Subcutaneous panniculitis-like T-cell lymphoma]] |
| | | |
− | *[[Mycosis Fungoides]] | + | *[[HAEM5:Mycosis fungoides]] |
| | | |
− | *[[Sézary Syndrome]] | + | *[[HAEM5:Sezary syndrome]] |
| | | |
− | *[[Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders]] | + | *[[HAEM4:Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders]] |
| | | |
− | - [[Lymphomatoid Papulosis]] | + | - [[HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis]] |
− | - [[Primary Cutaneous Anaplastic Large Cell Lymphoma]] | + | - [[HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma]] |
| | | |
− | *[[Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes]] | + | *[[HAEM4:Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes]] |
| | | |
− | - [[Primary Cutaneous Gamma Delta T-cell Lymphoma]] | + | - [[HAEM5:Primary cutaneous gamma/delta T-cell lymphoma]] |
− | - [[Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma]] | + | - [[HAEM5:Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma]] |
− | - [[Primary Cutaneous Acral CD8+ T-cell Lymphoma]] | + | - [[HAEM5:Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder]] |
− | - [[Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder]] | + | - [[HAEM5:Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]] |
| | | |
− | *[[Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)]] | + | *[[HAEM5:Peripheral T-cell lymphoma, NOS]] |
| | | |
− | *[[Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]] | + | *[[HAEM4:Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]] |
| | | |
− | - [[Angioimmunoblastic T-cell Lymphoma]] | + | - [[HAEM5:Nodal TFH cell lymphoma, angioimmunoblastic-type]] |
− | - [[Follicular T-cell Lymphoma]] | + | - [[HAEM5:Nodal TFH cell lymphoma, follicular-type]] |
− | - [[Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype]] | + | - [[HAEM5:Nodal TFH cell lymphoma, NOS]] |
| | | |
− | *[[Anaplastic Large Cell Lymphoma, ALK-Positive]] | + | *[[HAEM5:ALK-positive anaplastic large cell lymphoma]] |
| | | |
− | *[[Anaplastic Large Cell Lymphoma, ALK-Negative]] | + | *[[HAEM5:ALK-negative anaplastic large cell lymphoma]] |
| | | |
− | *[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]] | + | *[[HAEM5:Breast implant-associated anaplastic large cell lymphoma]] |
| | | |
− | ==Hodgkin Lymphomas ([[Hodgkin Lymphomas|Overview Page Link]])== | + | ==Hodgkin Lymphomas ([[HAEM4:Hodgkin Lymphomas|Overview Page Link]])== |
| | | |
− | *[[Nodular Lymphocyte Predominant Hodgkin Lymphoma]] | + | *[[HAEM5:Nodular lymphocyte predominant Hodgkin lymphoma]] |
| | | |
− | *[[Classic Hodgkin Lymphoma]] | + | *[[HAEM4:Classic Hodgkin Lymphoma]] |
| | | |
− | - [[Nodular Sclerosis Classic Hodgkin Lymphoma]] | + | - [[HAEM5:Classic Hodgkin lymphoma]] |
− | - [[Lymphocyte-Rich Classic Hodgkin Lymphoma]] | + | - [[HAEM5:Classic Hodgkin lymphoma]] |
− | - [[Mixed Cellularity Classic Hodgkin Lymphoma]] | + | - [[HAEM5:Classic Hodgkin lymphoma]] |
− | - [[Lymphocyte-Depleted Classic Hodgkin Lymphoma]] | + | - [[HAEM5:Classic Hodgkin lymphoma]] |
| | | |
− | ==Immunodeficiency-Associated Lymphoproliferative Disorders ([[Immunodeficiency-Associated Lymphoproliferative Disorders|Overview Page Link]])== | + | ==Immunodeficiency-Associated Lymphoproliferative Disorders ([[HAEM4:Immunodeficiency-Associated Lymphoproliferative Disorders|Overview Page Link]])== |
| | | |
− | *[[Lymphomas Associated with HIV Infection]] | + | *[[HAEM4:Lymphomas Associated with HIV Infection]] |
| | | |
− | *[[Post-Transplant Lymphoproliferative Disorders]] | + | *[[HAEM4:Post-Transplant Lymphoproliferative Disorders]] |
| | | |
− | - [[Non-Destructive Post-Transplant Lymphoproliferative Disorders]] | + | - [[HAEM4:Non-Destructive Post-Transplant Lymphoproliferative Disorders]] |
− | - [[Polymorphic Post-Transplant Lymphoproliferative Disorders]] | + | - [[HAEM5:Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation]] |
− | - [[Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)]] | + | - [[HAEM4:Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)]] |
− | - [[Monomorphic B-cell PTLD]] | + | - [[HAEM4:Monomorphic B-cell PTLD]] |
− | - [[Monomorphic T/NK-cell PTLD]] | + | - [[HAEM4:Monomorphic T/NK-cell PTLD]] |
− | - [[Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder]] | + | - [[HAEM4:Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder]] |
| | | |
− | *[[Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]] | + | *[[HAEM4:Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]] |
| | | |
− | ==Histiocytic and Dendritic Cell Neoplasms ([[Histiocytic and Dendritic Cell Neoplasms|Overview Page Link]])== | + | ==Histiocytic and Dendritic Cell Neoplasms ([[HAEM4:Histiocytic and Dendritic Cell Neoplasms|Overview Page Link]])== |
| | | |
− | *[[Histiocytic Sarcoma]] | + | *[[HAEM5:Histiocytic sarcoma]] |
| | | |
− | *[[Tumors Derived From Langerhans Cells]] | + | *[[HAEM4:Tumors Derived From Langerhans Cells]] |
| | | |
− | - [[Langerhans Cell Histiocytosis]] | + | - [[HAEM5:Langerhans cell histiocytosis]] |
− | - [[Langerhans Cell Sarcoma]] | + | - [[HAEM5:Langerhans cell sarcoma]] |
| | | |
− | *[[Indeterminate Dendritic Cell Tumour]] | + | *[[HAEM5:Indeterminate dendritic cell tumour]] |
| | | |
− | *[[Interdigitating Dendritic Cell Sarcoma]] | + | *[[HAEM5:Interdigitating dendritic cell sarcoma]] |
| | | |
− | *[[Follicular Dendritic Cell Sarcoma]] | + | *[[HAEM5:Follicular dendritic cell sarcoma]] |
| | | |
− | - [[Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma]] | + | - [[HAEM5:EBV-positive inflammatory follicular dendritic cell sarcoma]] |
| | | |
− | *[[Fibroblastic Reticular Cell Tumor]] | + | *[[HAEM5:Fibroblastic reticular cell tumour]] |
| | | |
− | *[[Disseminated Juvenile Xanthogranuloma]] | + | *[[HAEM5:Juvenile xanthogranuloma]] |
| | | |
− | *[[Erdheim-Chester Disease]] | + | *[[HAEM5:Erdheim-Chester disease]] |
| | | |
| ==Notes== | | ==Notes== |
| <nowiki>*</nowiki>The hierarchical tumour classification structure displayed on this page is reproduced from the [https://tumourclassification.iarc.who.int/welcome/ WHO Classification of Tumours] with permission from the copyright holder, ©International Agency for Research on Cancer. | | <nowiki>*</nowiki>The hierarchical tumour classification structure displayed on this page is reproduced from the [https://tumourclassification.iarc.who.int/welcome/ WHO Classification of Tumours] with permission from the copyright holder, ©International Agency for Research on Cancer. |